Overview
USPH market data
Price History
USPH price chart
Valuation & Profitability
- P/E (TTM)
- 33.76 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $2.61 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.12 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 229.6% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $58.19 – $93.50 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $1.2K · P/B 2.49 · P/S 1.47.
Company News
8-K filing — U S PHYSICAL THERAPY INC /NV (USPH)SEC EDGAR · Jul 6, 2026, 8:22 PM
U.S. Physical Therapy Acquires Majority Stake In Twelve-Clinic Physical Therapy Practice; Financial Terms UndisclosedBenzinga · Jul 2, 2026, 11:40 AM
Citizens Reiterates Market Outperform on US Physical Therapy, Maintains $98 Price TargetBenzinga · Jun 24, 2026, 1:15 PM
U.S. Physical Therapy Presented at the BofA Securities 2026 Healthcare ConferenceBenzinga · May 14, 2026, 12:30 PM
Barrington Research Maintains Outperform on US Physical Therapy, Lowers Price Target to $90Benzinga · May 13, 2026, 1:09 PM
U.S. Physical Therapy Reports Record First Quarter Revenue, Reaffirms Full Year GuidanceBenzinga · May 6, 2026, 9:05 PM